Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Fallopian Tube Cancer Market - A Global and Regional Analysis: Focus on Type, Treatment Type, End User, and Region, 2025-2035" report has been added to ...

Instead, it starts in the fallopian tubes, the narrow passages that connect the ovaries to the uterus. This finding could ...

The discovery that most ovarian cancers start, not in the ovaries, but the Fallopian tubes, means there may be a way to help prevent a disease that kills about 1000 women in Australia each year. It ...

Exclusive: Mumsnet survey shows half of female patients feel they have been ignored or dismissed by medics ...

Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ...

SANTA CLARA, Calif., February 12, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code ...

Evidence-based recommendations on niraparib (Zejula) for maintenance treatment of advanced (FIGO stages 3 and 4) ovarian, fallopian tube or peritoneal cancer after response to first-line ...

If Katija Cortez is certain about one thing in her life, it’s that she’s got absolutely no interest in having children. For her, it’s never been a ‘someday’ or ‘maybe later’ situation. It’s always ...

Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code SK006, as the only FDA-approved companion diagnostic ...

In a landmark achievement for public healthcare in Maharashtra, Cama and Albless Hospital has successfully performed its first embryo transfer procedure for a case of primary infertility caused by ...

Niraparib can be used as an option for the maintenance treatment of advanced epithelial (FIGO stages 3 and 4) high-grade ovarian, fallopian tube or primary peritoneal cancer after a response to ...